{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:28:43Z","timestamp":1790882923814,"version":"4.1.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Orthop Relat Res"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Synthetic composites of calcium phosphate and calcium sulfate have been used for grafting after intralesional curettage of benign bone tumors. However, there are limited studies on the outcomes of children who were grafted with these materials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Questions\/purposes<\/jats:title>\n                    <jats:p>(1) What proportion of patients with benign pediatric bone lesions who were treated with synthetic calcium phosphate and calcium sulfate bone substitute as a bone void filler experienced radiographic graft resorption by 1 year after treatment? (2) What proportion of patients thus treated experienced recurrence of the tumor or fracture at a minimum follow-up time of 1 year?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between 2020 and 2023, a total of 42 patients were surgically treated for benign lytic bone tumors or bone cysts at a single tertiary academic children\u2019s hospital. Two were excluded from analysis (one because it was a recurrent aneurysmal bone cyst initially treated with curettage and bone grafting, and one who was treated with aspiration and corticosteroid injection of the cyst at the family\u2019s request), leaving 40 who were treated with curettage and grafting using synthetic calcium phosphate and calcium sulfate bone substitute. All had at least 12 months of follow-up (mean \u00b1 SD 32 \u00b1 15 months) and were analyzed in this retrospective study. Of the patients, 30% (12 of 40) were female, and the mean age of the cohort was 12 \u00b1 4 years. During this time, adjunctive internal fixation hardware was generally used when there was a pathologic fracture, and based on those indications, 23% (9 of 40) received hardware. To answer our first study question about the proportion of lesions that demonstrated graft resorption by 1 year after treatment, we annotated the lesions and assessed for percent resorption at 6 weeks, 12 weeks, 6 months, 9 months, and 12 months. To answer our second study question, we used a Kaplan-Meier survivorship estimator to determine survivorship free from recurrence and survivorship free from fracture.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eighty-eight percent (35 of 40) developed complete resorption of the graft by 1 year after surgery; 45% (18 of 40) demonstrated this finding by 4 months after surgery. Thirteen percent (5) of patients developed local recurrence. Survivorship free from local recurrence was 88% (95% confidence interval [CI] 77% to 99%) at 1 year, and survivorship free from fracture was 100% (95% CI not estimable) at 1 year. Of those that recurred, there were three aneurysmal bone cysts, one unicameral bone cyst, and one chondroblastoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The bone substitute was associated with gradual resorption, low recurrence rates, and no fractures in this cohort. With the right indications, patients can start weightbearing at 6 weeks without hardware augmentation. Close monitoring is crucial, especially for aneurysmal bone cysts that have a higher risk of recurrence. Further research may be needed to compare the effectiveness and cost-efficiency of bone substitutes and alternative graft options.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence<\/jats:title>\n                    <jats:p>Level IV, therapeutic study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/corr.0000000000003752","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T03:00:08Z","timestamp":1764126008000},"page":"684-691","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["What Proportion of Patients Treated With Calcium Phosphate and Calcium Sulfate Bone Substitutes for Benign Pediatric Bone Tumors Develop Recurrent Lesions?"],"prefix":"10.1097","volume":"484","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8441-2261","authenticated-orcid":false,"given":"Barlas","family":"Goker","sequence":"first","affiliation":[{"name":"Department of Orthopedic Surgery, NYU Langone Medical Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maralexa","family":"Martinez-Valcarcel","sequence":"additional","affiliation":[{"name":"Ponce Health Sciences, University School of Medicine, Ponce, PR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Cianchini","sequence":"additional","affiliation":[{"name":"Universidad Central del Caribe, Bayam\u00f3n, PR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim Z.","family":"Masrouha","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, NYU Langone Medical Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"R1-20260721","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.actbio.2014.09.028","article-title":"Enhanced effect of \u03b2-tricalcium phosphate phase on neovascularization of porous calcium phosphate ceramics: in vitro and in vivo evidence","volume":"11","author":"Chen","year":"2015","journal-title":"Acta Biomater"},{"key":"R2-20260721","doi-asserted-by":"crossref","first-page":"e957","DOI":"10.1097\/BPO.0000000000002780","article-title":"Complications of hardware removal in pediatric orthopaedic surgery","volume":"44","author":"Desai","year":"2024","journal-title":"J Pediatr Orthop"},{"key":"R3-20260721","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.3928\/01477447-20130122-25","article-title":"Use of a calcium sulfate-calcium phosphate synthetic bone graft composite in the surgical management of primary bone tumors","volume":"36","author":"Evaniew","year":"2013","journal-title":"Orthopedics"},{"key":"R4-20260721","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/jor.25965","article-title":"Locking plate augmentation of polymethylmethacrylate-filled distal femoral defects: a biomechanical study","volume":"43","author":"Ferlauto","year":"2025","journal-title":"J Orthop Res."},{"key":"R5-20260721","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/1602400220","article-title":"Bioceramic bone graft substitute for treatment of unicameral bone cysts","volume":"24","author":"Fillingham","year":"2016","journal-title":"J Orthop Surg (Hong Kong)"},{"key":"R6-20260721","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/BPO.0b013e318285c56c","article-title":"Treatment of unicameral bone cysts in pediatric patients with an injectable regenerative graft: a preliminary report","volume":"33","author":"Gentile","year":"2013","journal-title":"J Pediatr Orthop"},{"key":"R7-20260721","doi-asserted-by":"crossref","first-page":"10225536241254200","DOI":"10.1177\/10225536241254200","article-title":"Time to full weight-bearing with the use of a calcium sulfate-calcium phosphate bone substitute as a bone void filler following extended curettage in the treatment of primary benign bone tumours","volume":"32","author":"Gyemi","year":"2024","journal-title":"J Orthop Surg (Hong Kong)"},{"key":"R8-20260721","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/jbm.b.34132","article-title":"Healing bone lesion defects using injectable CaSO(4) \/CaPO(4) -TCP bone graft substitute compared to cancellous allograft bone chips in a canine model","volume":"107","author":"Hall","year":"2019","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"R9-20260721","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00003086-198912000-00027","article-title":"Metastatic disease in long bones: a proposed scoring system for diagnosing impending pathologic fractures","volume":"249","author":"Mirels","year":"1989","journal-title":"Clin Orthop Relat Res"},{"key":"R10-20260721","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1097\/BPO.0000000000001680","article-title":"Synthetic bone graft substitute for treatment of unicameral bone cysts","volume":"41","author":"Nunziato","year":"2021","journal-title":"J Pediatr Orthop"},{"key":"R11-20260721","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.carj.2014.11.004","article-title":"Chronology of the radiographic appearances of the calcium sulfate-calcium phosphate synthetic bone graft composite following resection of bone tumors: a follow-up study of postoperative appearances","volume":"67","author":"Tan","year":"2016","journal-title":"Can Assoc Radiol J."},{"key":"R12-20260721","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/BLO.0b013e318059b902","article-title":"Increased bone formation using calcium sulfate-calcium phosphate composite graft","volume":"459","author":"Urban","year":"2007","journal-title":"Clin Orthop Relat Res"},{"key":"R13-20260721","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jot.2015.11.002","article-title":"Tissue reaction and material biodegradation of a calcium sulfate\/apatite biphasic bone substitute in rat muscle","volume":"6","author":"Wang","year":"2016","journal-title":"J Orthop Translat"}],"container-title":["Clinical Orthopaedics &amp; Related Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CORR.0000000000003752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:01:14Z","timestamp":1784628074000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CORR.0000000000003752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/corr.0000000000003752","relation":{},"ISSN":["0009-921X","1528-1132"],"issn-type":[{"value":"0009-921X","type":"print"},{"value":"1528-1132","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"2025-07-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}